Your browser doesn't support javascript.
loading
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.
Tiberi, Simon; Sotgiu, Giovanni; D'Ambrosio, Lia; Centis, Rosella; Arbex, Marcos Abdo; Alarcon Arrascue, Edith; Alffenaar, Jan Willem; Caminero, Jose A; Gaga, Mina; Gualano, Gina; Skrahina, Alena; Solovic, Ivan; Sulis, Giorgia; Tadolini, Marina; Alarcon Guizado, Valentina; De Lorenzo, Saverio; Roby Arias, Aurora Jazmín; Scardigli, Anna; Akkerman, Onno W; Aleksa, Alena; Artsukevich, Janina; Avchinko, Vera; Bonini, Eduardo Henrique; Chong Marín, Félix Antonio; Collahuazo López, Lorena; de Vries, Gerard; Dore, Simone; Kunst, Heinke; Matteelli, Alberto; Moschos, Charalampos; Palmieri, Fabrizio; Papavasileiou, Apostolos; Payen, Marie-Christine; Piana, Andrea; Spanevello, Antonio; Vargas Vasquez, Dante; Viggiani, Pietro; White, Veronica; Zumla, Alimuddin; Migliori, Giovanni Battista.
Afiliação
  • Tiberi S; Division of Infection.
  • Sotgiu G; Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari.
  • D'Ambrosio L; WHO Collaborating Centre for TB and Lung Diseases Public Health Consulting Group, Lugano, Switzerland.
  • Centis R; WHO Collaborating Centre for TB and Lung Diseases.
  • Arbex MA; University Center of Araraquara Hospital Nestor Goulart Reis, São Paulo State Secretary of Health, Brazil.
  • Alarcon Arrascue E; International Union against Tuberculosis and Lung Disease (The Union) MDR-TB Unit, Tuberculosis Division.
  • Alffenaar JW; Departments of Clinical Pharmacy and Pharmacology.
  • Caminero JA; MDR-TB Unit, Tuberculosis Division Pneumology Department, Hospital General de Gran Canaria "Dr. Negrin," Las Palmas de Gran Canaria, Spain.
  • Gaga M; National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Greece.
  • Gualano G; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani," Rome.
  • Skrahina A; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk.
  • Solovic I; National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, Slovakia.
  • Sulis G; University Department of Infectious and Tropical Diseases, World Health Organization Collaborating Centre for TB/HIV Coinfection and for TB Elimination, University of Brescia and Brescia Spedali Civili General Hospital.
  • Tadolini M; Unit of Infectious Diseases, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna.
  • Alarcon Guizado V; National Tuberculosis Control Programme, Ministry of Health.
  • De Lorenzo S; AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo.
  • Roby Arias AJ; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador.
  • Scardigli A; International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
  • Akkerman OW; Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, TB Center Beatrixoord.
  • Aleksa A; Educational Institution, Grodno State Medical University, Belarus.
  • Artsukevich J; Educational Institution, Grodno State Medical University, Belarus.
  • Avchinko V; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk.
  • Bonini EH; University Center of Araraquara Hospital Nestor Goulart Reis, São Paulo State Secretary of Health, Brazil.
  • Chong Marín FA; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador.
  • Collahuazo López L; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador.
  • de Vries G; KNCV Tuberculosis Foundation, Den Haag, The Netherlands.
  • Dore S; Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari.
  • Kunst H; Department of Respiratory Medicine, Queen Mary University.
  • Matteelli A; University Department of Infectious and Tropical Diseases, World Health Organization Collaborating Centre for TB/HIV Coinfection and for TB Elimination, University of Brescia and Brescia Spedali Civili General Hospital.
  • Moschos C; National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Greece.
  • Palmieri F; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani," Rome.
  • Papavasileiou A; National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Greece.
  • Payen MC; Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles, Belgium.
  • Piana A; Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari.
  • Spanevello A; Pneumology Unit, Fondazione S. Maugeri, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Clinical and Research Institute, Tradate Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.
  • Vargas Vasquez D; National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, Perù
  • Viggiani P; AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo.
  • White V; Department of Respiratory Medicine, Barts Health NHS Trust.
  • Zumla A; Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, United Kingdom.
  • Migliori GB; WHO Collaborating Centre for TB and Lung Diseases.
Clin Infect Dis ; 62(9): 1188-90, 2016 May 01.
Article em En | MEDLINE | ID: mdl-26908794
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Imipenem / Ácido Clavulânico / Tuberculose Extensivamente Resistente a Medicamentos / Antituberculosos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Imipenem / Ácido Clavulânico / Tuberculose Extensivamente Resistente a Medicamentos / Antituberculosos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Ano de publicação: 2016 Tipo de documento: Article